世界の家畜用ワクチン市場インサイト及び予測(足&口病気ワクチン、豚リングワクチン、鳥インフルエンザワクチン、豚青耳ワクチン、豚熱ワクチン)

◆英語タイトル:Global Livestock Vaccines Market Insights, Forecast to 2028

QYResearchが発行した調査報告書(QY22JLX10399)◆商品コード:QY22JLX10399
◆発行会社(リサーチ会社):QYResearch
◆発行日:2022年7月(※2025年版があります。お問い合わせください。)
◆ページ数:112
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥744,800見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,117,200見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,489,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、家畜用ワクチンのグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に家畜用ワクチンの世界市場のxxx%を占める「足&口病気ワクチン」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「豚」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
家畜用ワクチンの中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパの家畜用ワクチン市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

家畜用ワクチンのグローバル主要企業には、Merck、Boehringer Ingelheim、Ceva、Zoetis、Vaxxinova®、Elanco、QYH Biotech Co., Ltd、Pulike、Phibro Animal Health Corporation、JinYu Biotechnology、Harbin Pharmaceutical Group、MEVAC、Venky's、Japfa Comfeed Indonesia、Nisseiken、Hile、Hester Biosciencesなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

家畜用ワクチン市場は、種類と用途によって区分されます。世界の家畜用ワクチン市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
足&口病気ワクチン、豚リングワクチン、鳥インフルエンザワクチン、豚青耳ワクチン、豚熱ワクチン

【用途別セグメント】
豚、牛、羊、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- 家畜用ワクチン製品概要
- 種類別市場(足&口病気ワクチン、豚リングワクチン、鳥インフルエンザワクチン、豚青耳ワクチン、豚熱ワクチン)
- 用途別市場(豚、牛、羊、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界の家畜用ワクチン販売量予測2017-2028
- 世界の家畜用ワクチン売上予測2017-2028
- 家畜用ワクチンの地域別販売量
- 家畜用ワクチンの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別家畜用ワクチン販売量
- 主要メーカー別家畜用ワクチン売上
- 主要メーカー別家畜用ワクチン価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(足&口病気ワクチン、豚リングワクチン、鳥インフルエンザワクチン、豚青耳ワクチン、豚熱ワクチン)
- 家畜用ワクチンの種類別販売量
- 家畜用ワクチンの種類別売上
- 家畜用ワクチンの種類別価格
・用途別市場規模(豚、牛、羊、その他)
- 家畜用ワクチンの用途別販売量
- 家畜用ワクチンの用途別売上
- 家畜用ワクチンの用途別価格
・北米市場
- 北米の家畜用ワクチン市場規模(種類別、用途別)
- 主要国別の家畜用ワクチン市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパの家畜用ワクチン市場規模(種類別、用途別)
- 主要国別の家畜用ワクチン市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋の家畜用ワクチン市場規模(種類別、用途別)
- 主要国別の家畜用ワクチン市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米の家畜用ワクチン市場規模(種類別、用途別)
- 主要国別の家畜用ワクチン市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカの家畜用ワクチン市場規模(種類別、用途別)
- 主要国別の家畜用ワクチン市場規模(トルコ、サウジアラビア)
・企業情報
Merck、Boehringer Ingelheim、Ceva、Zoetis、Vaxxinova®、Elanco、QYH Biotech Co., Ltd、Pulike、Phibro Animal Health Corporation、JinYu Biotechnology、Harbin Pharmaceutical Group、MEVAC、Venky's、Japfa Comfeed Indonesia、Nisseiken、Hile、Hester Biosciences
・産業チェーン及び販売チャネル分析
- 家畜用ワクチンの産業チェーン分析
- 家畜用ワクチンの原材料
- 家畜用ワクチンの生産プロセス
- 家畜用ワクチンの販売及びマーケティング
- 家畜用ワクチンの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 家畜用ワクチンの産業動向
- 家畜用ワクチンのマーケットドライバー
- 家畜用ワクチンの課題
- 家畜用ワクチンの阻害要因
・主な調査結果

Market Analysis and Insights: Global Livestock Vaccines Market
Due to the COVID-19 pandemic, the global Livestock Vaccines market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Foot and Mouth Disease Vaccine accounting for % of the Livestock Vaccines global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Pig segment is altered to an % CAGR throughout this forecast period.
China Livestock Vaccines market size is valued at US$ million in 2021, while the US and Europe Livestock Vaccines are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Livestock Vaccines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Livestock Vaccines include Merck, Boehringer Ingelheim, Ceva, Zoetis, Vaxxinova®, Elanco, QYH Biotech Co., Ltd, Pulike and Phibro Animal Health Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Livestock Vaccines Scope and Segment
Livestock Vaccines market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Livestock Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Foot and Mouth Disease Vaccine
Pig Ring Vaccine
Bird Flu Vaccine
Porcine Blue Ear Vaccine
Swine Fever Vaccine
Segment by Application
Pig
Cattle and Sheep
Others
By Company
Merck
Boehringer Ingelheim
Ceva
Zoetis
Vaxxinova®
Elanco
QYH Biotech Co., Ltd
Pulike
Phibro Animal Health Corporation
JinYu Biotechnology
Harbin Pharmaceutical Group
MEVAC
Venky’s
Japfa Comfeed Indonesia
Nisseiken
Hile
Hester Biosciences
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Livestock Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Livestock Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Foot and Mouth Disease Vaccine
1.2.3 Pig Ring Vaccine
1.2.4 Bird Flu Vaccine
1.2.5 Porcine Blue Ear Vaccine
1.2.6 Swine Fever Vaccine
1.3 Market by Application
1.3.1 Global Livestock Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pig
1.3.3 Cattle and Sheep
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Livestock Vaccines Sales Estimates and Forecasts 2017-2028
2.2 Global Livestock Vaccines Revenue Estimates and Forecasts 2017-2028
2.3 Global Livestock Vaccines Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Livestock Vaccines Sales by Region
2.4.1 Global Livestock Vaccines Sales by Region (2017-2022)
2.4.2 Global Sales Livestock Vaccines by Region (2023-2028)
2.5 Global Livestock Vaccines Revenue by Region
2.5.1 Global Livestock Vaccines Revenue by Region (2017-2022)
2.5.2 Global Livestock Vaccines Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Livestock Vaccines Sales by Manufacturers
3.1.1 Global Top Livestock Vaccines Manufacturers by Sales (2017-2022)
3.1.2 Global Livestock Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Livestock Vaccines in 2021
3.2 Global Livestock Vaccines Revenue by Manufacturers
3.2.1 Global Livestock Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Global Livestock Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Livestock Vaccines Revenue in 2021
3.3 Global Livestock Vaccines Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Livestock Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Livestock Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Livestock Vaccines Sales by Type
4.1.1 Global Livestock Vaccines Historical Sales by Type (2017-2022)
4.1.2 Global Livestock Vaccines Forecasted Sales by Type (2023-2028)
4.1.3 Global Livestock Vaccines Sales Market Share by Type (2017-2028)
4.2 Global Livestock Vaccines Revenue by Type
4.2.1 Global Livestock Vaccines Historical Revenue by Type (2017-2022)
4.2.2 Global Livestock Vaccines Forecasted Revenue by Type (2023-2028)
4.2.3 Global Livestock Vaccines Revenue Market Share by Type (2017-2028)
4.3 Global Livestock Vaccines Price by Type
4.3.1 Global Livestock Vaccines Price by Type (2017-2022)
4.3.2 Global Livestock Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Livestock Vaccines Sales by Application
5.1.1 Global Livestock Vaccines Historical Sales by Application (2017-2022)
5.1.2 Global Livestock Vaccines Forecasted Sales by Application (2023-2028)
5.1.3 Global Livestock Vaccines Sales Market Share by Application (2017-2028)
5.2 Global Livestock Vaccines Revenue by Application
5.2.1 Global Livestock Vaccines Historical Revenue by Application (2017-2022)
5.2.2 Global Livestock Vaccines Forecasted Revenue by Application (2023-2028)
5.2.3 Global Livestock Vaccines Revenue Market Share by Application (2017-2028)
5.3 Global Livestock Vaccines Price by Application
5.3.1 Global Livestock Vaccines Price by Application (2017-2022)
5.3.2 Global Livestock Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Livestock Vaccines Market Size by Type
6.1.1 North America Livestock Vaccines Sales by Type (2017-2028)
6.1.2 North America Livestock Vaccines Revenue by Type (2017-2028)
6.2 North America Livestock Vaccines Market Size by Application
6.2.1 North America Livestock Vaccines Sales by Application (2017-2028)
6.2.2 North America Livestock Vaccines Revenue by Application (2017-2028)
6.3 North America Livestock Vaccines Market Size by Country
6.3.1 North America Livestock Vaccines Sales by Country (2017-2028)
6.3.2 North America Livestock Vaccines Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Livestock Vaccines Market Size by Type
7.1.1 Europe Livestock Vaccines Sales by Type (2017-2028)
7.1.2 Europe Livestock Vaccines Revenue by Type (2017-2028)
7.2 Europe Livestock Vaccines Market Size by Application
7.2.1 Europe Livestock Vaccines Sales by Application (2017-2028)
7.2.2 Europe Livestock Vaccines Revenue by Application (2017-2028)
7.3 Europe Livestock Vaccines Market Size by Country
7.3.1 Europe Livestock Vaccines Sales by Country (2017-2028)
7.3.2 Europe Livestock Vaccines Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Livestock Vaccines Market Size by Type
8.1.1 Asia Pacific Livestock Vaccines Sales by Type (2017-2028)
8.1.2 Asia Pacific Livestock Vaccines Revenue by Type (2017-2028)
8.2 Asia Pacific Livestock Vaccines Market Size by Application
8.2.1 Asia Pacific Livestock Vaccines Sales by Application (2017-2028)
8.2.2 Asia Pacific Livestock Vaccines Revenue by Application (2017-2028)
8.3 Asia Pacific Livestock Vaccines Market Size by Region
8.3.1 Asia Pacific Livestock Vaccines Sales by Region (2017-2028)
8.3.2 Asia Pacific Livestock Vaccines Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Livestock Vaccines Market Size by Type
9.1.1 Latin America Livestock Vaccines Sales by Type (2017-2028)
9.1.2 Latin America Livestock Vaccines Revenue by Type (2017-2028)
9.2 Latin America Livestock Vaccines Market Size by Application
9.2.1 Latin America Livestock Vaccines Sales by Application (2017-2028)
9.2.2 Latin America Livestock Vaccines Revenue by Application (2017-2028)
9.3 Latin America Livestock Vaccines Market Size by Country
9.3.1 Latin America Livestock Vaccines Sales by Country (2017-2028)
9.3.2 Latin America Livestock Vaccines Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Livestock Vaccines Market Size by Type
10.1.1 Middle East and Africa Livestock Vaccines Sales by Type (2017-2028)
10.1.2 Middle East and Africa Livestock Vaccines Revenue by Type (2017-2028)
10.2 Middle East and Africa Livestock Vaccines Market Size by Application
10.2.1 Middle East and Africa Livestock Vaccines Sales by Application (2017-2028)
10.2.2 Middle East and Africa Livestock Vaccines Revenue by Application (2017-2028)
10.3 Middle East and Africa Livestock Vaccines Market Size by Country
10.3.1 Middle East and Africa Livestock Vaccines Sales by Country (2017-2028)
10.3.2 Middle East and Africa Livestock Vaccines Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Overview
11.1.3 Merck Livestock Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Merck Livestock Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Corporation Information
11.2.2 Boehringer Ingelheim Overview
11.2.3 Boehringer Ingelheim Livestock Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Boehringer Ingelheim Livestock Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Boehringer Ingelheim Recent Developments
11.3 Ceva
11.3.1 Ceva Corporation Information
11.3.2 Ceva Overview
11.3.3 Ceva Livestock Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Ceva Livestock Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Ceva Recent Developments
11.4 Zoetis
11.4.1 Zoetis Corporation Information
11.4.2 Zoetis Overview
11.4.3 Zoetis Livestock Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Zoetis Livestock Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Zoetis Recent Developments
11.5 Vaxxinova®
11.5.1 Vaxxinova® Corporation Information
11.5.2 Vaxxinova® Overview
11.5.3 Vaxxinova® Livestock Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Vaxxinova® Livestock Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Vaxxinova® Recent Developments
11.6 Elanco
11.6.1 Elanco Corporation Information
11.6.2 Elanco Overview
11.6.3 Elanco Livestock Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Elanco Livestock Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Elanco Recent Developments
11.7 QYH Biotech Co., Ltd
11.7.1 QYH Biotech Co., Ltd Corporation Information
11.7.2 QYH Biotech Co., Ltd Overview
11.7.3 QYH Biotech Co., Ltd Livestock Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 QYH Biotech Co., Ltd Livestock Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 QYH Biotech Co., Ltd Recent Developments
11.8 Pulike
11.8.1 Pulike Corporation Information
11.8.2 Pulike Overview
11.8.3 Pulike Livestock Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Pulike Livestock Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Pulike Recent Developments
11.9 Phibro Animal Health Corporation
11.9.1 Phibro Animal Health Corporation Corporation Information
11.9.2 Phibro Animal Health Corporation Overview
11.9.3 Phibro Animal Health Corporation Livestock Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Phibro Animal Health Corporation Livestock Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Phibro Animal Health Corporation Recent Developments
11.10 JinYu Biotechnology
11.10.1 JinYu Biotechnology Corporation Information
11.10.2 JinYu Biotechnology Overview
11.10.3 JinYu Biotechnology Livestock Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 JinYu Biotechnology Livestock Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 JinYu Biotechnology Recent Developments
11.11 Harbin Pharmaceutical Group
11.11.1 Harbin Pharmaceutical Group Corporation Information
11.11.2 Harbin Pharmaceutical Group Overview
11.11.3 Harbin Pharmaceutical Group Livestock Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Harbin Pharmaceutical Group Livestock Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Harbin Pharmaceutical Group Recent Developments
11.12 MEVAC
11.12.1 MEVAC Corporation Information
11.12.2 MEVAC Overview
11.12.3 MEVAC Livestock Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 MEVAC Livestock Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 MEVAC Recent Developments
11.13 Venky’s
11.13.1 Venky’s Corporation Information
11.13.2 Venky’s Overview
11.13.3 Venky’s Livestock Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Venky’s Livestock Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Venky’s Recent Developments
11.14 Japfa Comfeed Indonesia
11.14.1 Japfa Comfeed Indonesia Corporation Information
11.14.2 Japfa Comfeed Indonesia Overview
11.14.3 Japfa Comfeed Indonesia Livestock Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Japfa Comfeed Indonesia Livestock Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Japfa Comfeed Indonesia Recent Developments
11.15 Nisseiken
11.15.1 Nisseiken Corporation Information
11.15.2 Nisseiken Overview
11.15.3 Nisseiken Livestock Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Nisseiken Livestock Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Nisseiken Recent Developments
11.16 Hile
11.16.1 Hile Corporation Information
11.16.2 Hile Overview
11.16.3 Hile Livestock Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Hile Livestock Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Hile Recent Developments
11.17 Hester Biosciences
11.17.1 Hester Biosciences Corporation Information
11.17.2 Hester Biosciences Overview
11.17.3 Hester Biosciences Livestock Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Hester Biosciences Livestock Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Hester Biosciences Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Livestock Vaccines Industry Chain Analysis
12.2 Livestock Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Livestock Vaccines Production Mode & Process
12.4 Livestock Vaccines Sales and Marketing
12.4.1 Livestock Vaccines Sales Channels
12.4.2 Livestock Vaccines Distributors
12.5 Livestock Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Livestock Vaccines Industry Trends
13.2 Livestock Vaccines Market Drivers
13.3 Livestock Vaccines Market Challenges
13.4 Livestock Vaccines Market Restraints
14 Key Findings in The Global Livestock Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の家畜用ワクチン市場インサイト及び予測(足&口病気ワクチン、豚リングワクチン、鳥インフルエンザワクチン、豚青耳ワクチン、豚熱ワクチン)(Global Livestock Vaccines Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。